Software Testing Manager
About the job
- A bachelor's degree is required.
- At least five years of management experience is required.
- Fundamental understanding of proven testing techniques is required.
- Extensive knowledge of the software development life cycle is required, preferably in rapid-release environments.
- A proven record of success in a leadership role working cross-functionally under tight deadlines is required.
- Excellence and attention to detail are required.
- A positive attitude and strong communication and interpersonal skills are required.
- Manage and provide leadership for Study Testing employees, including hiring, development, performance management, coaching, counseling, and termination.
- Develop and implement a testing strategy across web and mobile platforms.
- Design and manage a scalable testing process and system through organizational growth and changes.
- Lead exploratory testing, bug investigation, regression testing, and integration testing.
- Provide technical guidance for test design, test development, test execution, test cycles, gap analysis, and traceability matrices.
- Collaborate continuously with Development and Application Testing teams.
- Establish cross-functional process-improvement methods to prevent redundant issues from reaching the testing phase.
- Promote quality and accountability by setting study quality goals and tracking and reporting progress across Study Build Teams.
- Maintain subject matter expertise by studying testing trends and developments, participating in educational opportunities and professional organizations, and reading professional publications.
- Clinical trial lifecycle experience is preferred.
- Experience in regulated environments such as the Food and Drug Administration is preferred.
About the company
Clinical Ink provides digital tools for clinical trials, focusing on eSource solutions such as Direct Data Capture (DDC), electronic Clinical Outcome Assessments (eCOA), electronic Patient-Reported Outcomes (ePRO), and electronic Consent (eConsent). These tools work by digitizing data collection and patient interactions: DDC captures data directly from sources, eCOA and ePRO collect outcomes and patient input electronically, and eConsent manages informed consent digitally—often via a subscription-based platform with optional rapid-build timelines and virtual trial support. The company differentiates itself through an end-to-end, scalable digital suite that emphasizes patient-centric data capture and global reach, aiming to streamline trials more than traditional, paper-based or disjointed systems. Its goal is to improve the quality and efficiency of clinical trials by delivering integrated, compliant eSource solutions to pharmaceutical companies, CROs, and academic institutions.
Company Size
201-500
Company Stage
Early VC
Total Funding
$15M
Headquarters
Winston-Salem, North Carolina
Founded
2007
Get referred to Clinical Ink
See people who can refer or advise you
Simplify's Take
What believers are saying
- April 13, 2026 Kaitality and February 27, 2026 Djurhuus appointment opened a new disease-management line.
- The August 2026 Android app update proves active product investment and operational maintenance.
- GI Partners acquired Clinical ink in 2025, adding capital for expansion and tuck-ins.
What critics are saying
- Veeva and Signant outspend Clinical ink on platform breadth, integrations, and enterprise lock-in.
- Clinical ink still lacks CTMS, eTMF, and RTSM, forcing buyers toward fuller suites.
- If GI Partners cannot scale sales after 2026, Clinical ink becomes a niche acquisition target.
What makes Clinical Ink unique
- Clinical ink spans eSource, eCOA, ePRO, and eConsent inside one workflow.
- April 13, 2026 Kaitality extends trial-grade adherence and device data into obesity care.
- Clinical ink’s 40+ language eConsent and BYOD app target global, diverse trials.
Help us improve and share your feedback! Did you find this helpful?